enVVeno Medical (NVNO) Operating Income (2017 - 2026)

enVVeno Medical's Operating Income history runs 10 years deep, the most recent figure standing at -$4.1 million for Q1 2026.

• In Q1 2026, Operating Income rose 18.01% year-over-year to -$4.1 million; the TTM figure through Mar 2026 stood at -$20.0 million (up 14.05% YoY), while the FY2025 annual figure was -$20.9 million, up 12.28% from the prior year.
• Operating Income was -$4.1 million for Q1 2026 at enVVeno Medical, down from -$4.0 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of -$4.0 million in Q4 2025 to a low of -$7.0 million in Q2 2025.
• Historically, Operating Income has averaged -$5.8 million across 5 years, with a median of -$6.2 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Operating Income plunged 192.79% in 2022, then jumped 40.1% in 2025.
• A 5-year view of Operating Income shows it stood at -$6.5 million in 2022, then increased by 2.82% to -$6.3 million in 2023, then slipped by 6.71% to -$6.7 million in 2024, then surged by 40.1% to -$4.0 million in 2025, then dropped by 1.22% to -$4.1 million in 2026.
• The last three Operating Income figures came in at -$4.1 million (Q1 2026), -$4.0 million (Q4 2025), and -$4.9 million (Q3 2025), per Business Quant data.